Real-World PD-L1 Testing Patterns for Patients with Advanced Non-Small Cell Lung Cancer in Greece

被引：0
|
作者：
Kokkotou, E. [1 ]
Charpidou, A. [1 ]
Papaspiliou, A. [1 ]
Stournara, L. [1 ]
Grammatikou, V. [2 ]
Ejzykowicz, F. [3 ]
Syrigos, K. [1 ]
机构：
[1] Sotiria Gen Hosp Athens, Athens Med Sch, Oncol Unit, Dept Med 3, Athens, Greece
[2] Msd Greece, Oncol Med Affairs, Athens, Greece
[3] Merck & Co Inc, Oncol Prod Line, Core, Kenilworth, NJ USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
advanced NSCLC; PD-L1; biomarker; immunotherapy;
D O I：
10.1016/j.jtho.2019.08.1397
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-54
引用
收藏
页码：S660 / S660
页数：1
相关论文
共 50 条
  • [21] Real-world treatment patterns and outcomes in PD-L1-positive non-small cell lung cancer
    Zhang, Xinke
    DeClue, Richard W.
    Herms, Lisa
    Yang, Mo
    Pawar, Vivek
    Masters, Elizabeth T.
    Ruisi, Mary
    Chin, Kevin
    Velcheti, Vamsidhar
    IMMUNOTHERAPY, 2021, 13 (18) : 1521 - 1533
  • [22] Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United States
    Velcheti, Vamsidhar
    Patwardhan, Pallavi D.
    Liu, Frank Xiaoqing
    Chen, Xin
    Cao, Xiting
    Burke, Thomas
    PLOS ONE, 2018, 13 (11):
  • [23] Real-world data analysis of PD-L1 expression and overall survival (OS) in advanced non-small cell lung cancer (aNSCLC)
    Staib, J.
    Sudarsanam, S.
    Byfield, S. Dacosta
    Kennedy, C.
    Weiss, L.
    ANNALS OF ONCOLOGY, 2019, 30 : 27 - 27
  • [24] PD-L1 expression for advanced non-small cell lung cancer patients with cancer cachexia
    Morimoto, Kenji
    Yamada, Tadaaki
    CANCER SCIENCE, 2023, 114 : 1410 - 1410
  • [25] Author Correction: Real-world evidence and clinical observations of the treatment of advanced non-small cell lung cancer with PD-1/PD-L1 inhibitors
    Peng Song
    Jingcheng Zhang
    Congcong Shang
    Li Zhang
    Scientific Reports, 10
  • [26] Real-world prospective data of small biopsy samples for tumor PD-L1 expression in non-small cell lung cancer
    Morikawa, K.
    Tsunoda, A.
    Inoue, T.
    Mineshita, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [27] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [28] PD-L1 heterogeneity in patients with non-small cell lung cancer
    Wei, Zhigang
    Fan, Linlin
    Yang, Xia
    Li, Jie
    Zhan, Xuemei
    Ye, Xin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (05) : E268 - E274
  • [29] PD-L1 immunohistochemistry in patients with non-small cell lung cancer
    Jotatsu, Takanobu
    Oda, Keishi
    Yatera, Kazuhiro
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S2127 - S2129
  • [30] Advanced non-small cell lung cancer: the role of PD-L1 inhibitors
    Heigener, David F.
    Reck, Martin
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1468 - S1473
12345